Literature DB >> 32855875

Short-Term Changes in Tear Lipid Layer Thickness After Instillation of Lipid Containing Eye Drops.

Phoebe Lim1, Tun Aung Han2, Louis Tong1,3,4,5.   

Abstract

Purpose: Lipid-containing eye drops is increasingly popular in eye clinics to treat dry eye. Tear lipid layer thickness (LLT) changes after instillation of lipid eye drops have not been characterized. We aim to evaluate these changes of LLT using a noninvasive interferometry-based method.
Methods: This prospective clinical study was conducted on staff and patients from Singapore National Eye Centre with ad hoc recruitment. Noninvasive tear break up time was measured using the Keratographer 5M. LLTs were measured using a tear interferometer machine before and at 1, 5, and 15 minutes after instillation of lipid-containing drops, either Cationorm unidose or Artelac Lipids. Fluorescein clearance (tear clearance rate) and Schirmer tests were conducted. The tear clearance rate of fluorescein dye was based on the visual examination of the color of a Schirmer strip after 5 minutes, compared against color standards.
Results: This study included a total of 84 participants aged ≥21 years. Many were female (92.8%) and Chinese (89.2%). A tear clearance rate of 1/16 was most common (35.7%), whereas 1/128 and 1/32 were uncommon (3.57% each). Schirmer results were 6.5 ± 8.1 mm, and noninvasive tear break up times were 8.12 ± 6.25 mm. Participants with baseline LLT <60 nm had greater changes in LLT after Cationorm instillation, compared with those with an LLT of >60 nm. LLT changes over 15 minutes were not associated with tear clearance rate. Similar results were obtained when using Artelac Lipids. Conclusions: Our results showed that participants' initial LLT affected their responsiveness to lipid-containing eye drops more than other factors. Translational Relevance: Doctors may choose to measure the baseline LLT of patients before deciding whether to prescribe lipid eye drops to patients. Copyright 2020 The Authors.

Entities:  

Keywords:  dry eye; imaging; lipid-containing eye drops; ocular surface disease; tear stability; treatment

Mesh:

Substances:

Year:  2020        PMID: 32855875      PMCID: PMC7422789          DOI: 10.1167/tvst.9.8.29

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  26 in total

1.  The economic burden of dry eye: a conceptual framework and preliminary assessment.

Authors:  Prabashni Reddy; Oren Grad; Krithika Rajagopalan
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

Review 2.  Choice of artificial tear formulation for patients with dry eye: where do we start?

Authors:  Louis Tong; Andrea Petznick; SzeYee Lee; Jeremy Tan
Journal:  Cornea       Date:  2012-11       Impact factor: 2.651

3.  Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.

Authors:  Francisco Pérez Bartolomé; Jose María Martínez de la Casa; Pedro Arriola Villalobos; Cristina Fernández Pérez; Vicente Polo; Ruben Sánchez Jean; Julián García Feijoó
Journal:  Semin Ophthalmol       Date:  2017-11-16       Impact factor: 1.975

4.  Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography.

Authors:  Piotr A Wozniak; Doreen Schmidl; Ahmed M Bata; Klemens Fondi; Katarzyna J Witkowska; Valentin Aranha Dos Santos; Carina Baar; Kim I Room; Johannes Nepp; Isabella Baumgartner; Alina Popa-Cherecheanu; Gerhard Garhöfer; René M Werkmeister; Leopold Schmetterer
Journal:  Acta Ophthalmol       Date:  2016-12-18       Impact factor: 3.761

5.  The Effect of Optive and Optive Advanced Artificial Tears on the Healthy Tear Film.

Authors:  Maria Markoulli; Amanda Sobbizadeh; Jacqueline Tan; Nancy Briggs; Minas Coroneo
Journal:  Curr Eye Res       Date:  2018-02-01       Impact factor: 2.424

6.  Dry eye: prevalence, utilization, and economic implications.

Authors:  Michael D Dalzell
Journal:  Manag Care       Date:  2003-12

7.  Tear lipid layer thickness with eye drops in meibomian gland dysfunction.

Authors:  Jennifer S Fogt; Matthew J Kowalski; P Ewen King-Smith; Alice T Epitropolous; Andrew J Hendershot; Carrie Lembach; John Paul Maszczak; Lisa A Jones-Jordan; Joseph T Barr
Journal:  Clin Ophthalmol       Date:  2016-11-07

8.  Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.

Authors:  Tanima Bose; Ryan Lee; Aihua Hou; Louis Tong; K George Chandy
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

9.  Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.

Authors:  Shilpa Gulati; Sandeep Jain
Journal:  Handb Exp Pharmacol       Date:  2017

10.  Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography.

Authors:  Yang Zhao; Anuradha Veerappan; Sharon Yeo; David M Rooney; Rajendra U Acharya; Jen Hong Tan; Louis Tong
Journal:  Eye Contact Lens       Date:  2016-11       Impact factor: 2.018

View more
  5 in total

1.  Lipid, Aqueous and Mucin Tear Film Layer Stability and Permanence within 0.15% Liposome Crosslinked Hyaluronic Acid versus 0.15% Non-Crosslinked Hyaluronic Acid Measured with a Novel Non-Invasive Ocular Surface Analyzer.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; María Carmen Sánchez-González
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Immediate Ocular Changes After Light-Emitting Diode Displays Exposure-A Preliminary Study.

Authors:  Chia-Chen Lin; Jia-Horung Hung; Yi-Hsun Huang
Journal:  Front Med (Lausanne)       Date:  2022-04-04

3.  Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework.

Authors:  Louis Tong; Li Lim; Donald Tan; Wee Jin Heng; Jimmy Lim; Cordelia Chan; Anshu Arundhati; Anna Tan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-11

4.  Oral isotretinoin for acne vulgaris side effects on the ocular surface: Hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms.

Authors:  María Carmen Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; José-María Sánchez-González
Journal:  Front Med (Lausanne)       Date:  2022-07-22

5.  Hyaluronic Acid and Galacto-Xyloglucan Eyedrop Efficacy in Young-Adult Oral Contraceptive Users of Childbearing Age.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; María Carmen Sánchez-González
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.